Funding Rounds
Synklino

Synklino Unknown (2019, $1M)

Synklino

Developer of a CMV-specific immunotoxin intended to eradicate cytomegalovirus infection.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Unknown

Raised Amount: $1.48M

Raised Date: 2019-01-01

Investors